• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Prematurity and gestational size are associated with increased risk of atrial fibrillation

byVincent SoandAlex Gipsman, MD
May 11, 2023
in Cardiology, Chronic Disease, Obstetrics, Pediatrics
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. In a multinational retrospective cohort study, preterm birth was associated with an increased risk of atrial fibrillation (AF).

2. Neonatal factors such as being small for gestational age were associated with increased AF risk before age 18 years and being large for gestational age was associated with AF at all age groups studied.

Evidence Rating Level: 2 (Good)

Study Rundown: Neonatal factors such as restricted (small for gestational age; SGA) or excess (large for gestational age; LGA) fetal growth have been linked to increased risk of cardiovascular diseases. One cardiovascular disease, atrial fibrillation (AF), is of importance as a common cardiac arrhythmia that is associated with significant morbidity. Although SGA and LGA are associated with several AF-specific risk factors (cardiometabolic disorders, hypertension), a direct association between abnormal fetal growth and AF has not been formally studied. To address this question, this study used a multinational cohort study design in Danish, Swedish, and Finnish health registries (n=8,012,433) to investigate the relationship between preterm birth, SGA, or LGA and risk of AF later in life. Those who were born SGA had an increased risk of developing AF by 18 years of life (but not later) and those born LGA had an increased risk of developing AF at any age. Prematurity was associated with an increased risk of AF which was more prominent in childhood than adulthood. Limitations of this study include missed cases of asymptomatic or mild AF, as well as AF that occurred after the follow-up period (maximum age of 49 years). This is a large cohort study that provides evidence that fetal growth and prematurity may influence the risk of developing AF later in life. Further studies are required to understand the pathophysiology of these risk factors whether the development of AF can be prevented.

Click here to read the article in JAMA Pediatrics

Relevant Reading: Birth weight and risk of coronary heart disease in adults: a meta-analysis of prospective cohort studies

RELATED REPORTS

Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

In-Depth [retrospective cohort]: Using a multinational cohort study design, this study linked several nationwide registers to health outcomes in patients in Denmark (singletons from 1978 to 2016, n= 2,332,882), Sweden (singletons from 1973 to 2014, n = 4,171,006), and Finland (random sample of 90% of singletons from 1987 to 2014, n = 1,636,116). The outcome of interest was AF and atrial flutter,  diagnosed based on International Classification of Diseases (ICD) codes. Follow-up started at birth and ended on the date of the first AF diagnosis, death, emigration, or the latest date with available data. The maximum age at the end of follow-up was 49 years (median 21 years; IQR 11.7 to 30.7 years). Of the patients included, 0.14% (11,464) had AF. Preterm birth was associated with increased AF risk within the first 18 years of life (aHR 2.36, 95% CI 1.90-2.94) and afterward (aHR 1.16, 95% CI 1.05-1.29). SGA was associated with an increased risk of AF up to age 18 years old (aHR 1.27, 95% CI 1.07-1.50), but was not associated with increased risk afterward (aHR 0.90, 95% CI 0.84-0.96). LGA was associated with an increased risk of AF before 18 years old (aHR 1.44, 95% CI 1.23-1.68) as well as afterward (aHR 1.56, 95% CI 1.47-1.66). The relationship between preterm birth, SGA, LGA, and AF risk did not differ by sex or country of birth. In general, being LGA and preterm were associated with an increased risk of AF when compared to LGA and term, and this relationship was more pronounced when <18 years of age.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: atrial fibrillationelectrophysiologyfetal growthlganeonatologyNICUprematuritySGA
Previous Post

No difference in outcomes after non-cardiac surgery with hypotension- versus hypertension-avoidance

Next Post

Delay of surgical treatment for melanoma up to 90 days not associated with poorer outcomes

RelatedReports

Cardiology

Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors

September 30, 2026
Cardiology

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

September 23, 2026
Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind September 7, 2026

September 7, 2026
Next Post
Women with pregnancy-associated melanoma at greater risk of metastasis, recurrence

Delay of surgical treatment for melanoma up to 90 days not associated with poorer outcomes

Musculoskeletal disease likely a risk factor for development of dementias

Differences in sudden unexpected infant death rates reported between states

Several individual- and state-level factors are associated with the level of participation in nutrition assistance for women, infants, and children

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients
  • Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans
  • A long-term gonadotropin-releasing hormone agonist protocol may be associated with increased positive pregnancy outcomes in women with endometriosis undergoing frozen embryo transfer
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.